An Economic Evaluation of Atorvastatin for Primary Prevention of Cardiovascular Events in Type 2 Diabetes

By Ramsey Scott D.   Clarke Lauren D.  

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 329-339

Adis International

Access to resources Recommend Favorite

Atorvastatin: A Pharmacoeconomic Review of its Use in the Primary and Secondary Prevention of Cardiovascular Events

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 25, Iss. 12, 2007-01 ,pp. : 1031-1053

Adis International

Access to resources Recommend Favorite

Fenofibrate: A Review of its Use in Primary Dyslipidaemia, the Metabolic Syndrome and Type 2 Diabetes Mellitus

By Keating Gillian M.   Croom Katherine F.  

Drugs, Vol. 67, Iss. 1, 2007-01 ,pp. : 121-153

Adis International

Access to resources Recommend Favorite

Statin Utilization Patterns for the Primary Prevention of Cardiovascular Events: A Retrospective Study in Patients with Diabetes Mellitus in Hong Kong

By Lee Vivian W.Y.   Ho Ivan C.H.   Chan Windy S.Y.   Kai Yin Tam   Lee Kenneth K.C.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 3, 2008-01 ,pp. : 199-205

Adis International

Access to resources Recommend Favorite

Exenatide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus (as an Adjunct to Metformin and/or a Sulfonylurea)

By Cvetković Risto S.   Plosker Greg L.  

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 935-954

Adis International

Access to resources Recommend Favorite